AU Stock MarketDetailed Quotes
ATHO Alterity Therapeutics Ltd
- 0.002
- -0.001-33.33%
20min DelayMarket Closed Jul 18 15:28 AET
0Market Cap0.00P/E (Static)
0.002High0.002Low1.70MVolume0.002Open0.003Pre Close3.40KTurnover0.00352wk High0.00%Turnover Ratio0Shares0.00152wk Low--EPS TTM0Float Cap0.003Historical High0.00P/E (Static)0Shs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Alterity Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expense | -5.18%14.35M | 2.70%15.14M | 9.45%14.74M | 7.96%13.47M | 12.47M |
| Selling and administrative expenses | -9.57%4.94M | -20.44%5.46M | 105.85%6.86M | -22.09%3.33M | --4.28M |
| -General and administrative expense | -9.57%4.94M | -20.44%5.46M | 105.85%6.86M | -22.09%3.33M | --4.28M |
| Research and development costs | -10.49%13.2M | 20.04%14.75M | 21.64%12.28M | -22.22%10.1M | --12.98M |
| Depreciation amortization depletion | 88.63%102.26K | -28.07%54.21K | -32.96%75.37K | 278.59%112.43K | --29.7K |
| -Depreciation and amortization | 88.63%102.26K | -28.07%54.21K | -32.96%75.37K | 278.59%112.43K | --29.7K |
| Other taxes | 16.17%-3.91M | -13.16%-4.67M | ---4.13M | --0 | ---4.95M |
| Other operating expenses | 106.49%29.4K | -27.01%-452.96K | -354.24%-356.63K | -159.05%-78.51K | --132.97K |
| Operating profit | 5.18%-14.35M | -2.70%-15.14M | -9.45%-14.74M | -7.96%-13.47M | -12.47M |
| Net non-operating interest income (expenses) | 556.39%16.44K | -87.89%2.5K | 20.79%20.68K | -84.23%17.12K | 108.54K |
| Non-operating interest income | 556.39%16.44K | -87.89%2.5K | 20.79%20.68K | -84.23%17.12K | --108.54K |
| Other net income (expenses) | -72.35%651.84K | 498.72%2.36M | -7,432.00%-591.34K | -129.11%-7.85K | 26.97K |
| Gain on sale of security | -65.66%934.8K | 1,276.96%2.72M | -167.03%-231.31K | -1.14%345.07K | --349.06K |
| Other non-operating income (expenses) | 22.40%-282.96K | -1.29%-364.67K | -2.01%-360.03K | -9.57%-352.92K | ---322.1K |
| Income before tax | -7.24%-13.7M | 16.54%-12.78M | -13.77%-15.31M | -9.07%-13.46M | -12.34M |
| Income tax | 49.21%104.46K | 70.01K | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||||
| Net income | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -12.34M |
| Net income continuous operations | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | ---12.34M |
| Noncontrolling interests | |||||
| Net income attributable to the company | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -12.34M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | |||||
| Net income attributable to common stockholders | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -12.34M |
| Diluted earnings per share | |||||
| Basic earnings per share | |||||
| Dividend per share | |||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg